当前位置:Public Access >页面
Chinese/English
Efficacy and safety of low molecular weight heparin in the prevention of acute necrotizing pancreatitis complicated with portal vein thrombosis: a multicenter, prospective, double-blind, randomized controlled trial

ChiCTR注册号:

Reg No. in ChiCTR:

ChiCTR1900023372

研究题目:

Efficacy and safety of low molecular weight heparin in the prevention of acute necrotizing pancreatitis complicated with portal vein thrombosis: a multicenter, prospective, double-blind, randomized controlled trial

Study title:

Efficacy and safety of low molecular weight heparin in the prevention of acute necrotizing pancreatitis complicated with portal vein thrombosis: a multicenter, prospective, double-blind, randomized controlled trial

 注册状况:

 Registration:

True

注册机构:

中国临床试验注册中心

Name of the Registry:

Chinese Clinical Trial Registry

项目负责人:

中国临床试验注册中心

Corresponding person:

Chinese Clinical Trial Registry

电话:

Telephone:

+86 0791-88692705

电子邮件

Email

lunonghua@ncu.edu.cn

通讯地址:

江西省南昌市永外正街17号

Address:

17 Yongwai Main Street, Nanchang, Jiangxi, China

邮政编码

Postcode

330006

项目负责人所有单位:

南昌大学第一附属医院

Institution:

The First Affiliated Hospital of Nanchang Universi

批准本研究的伦理委员会名称:

南昌大学第一附属医院临床医学伦理委员会

Name of the ethic committee:

The Clinical Ethics Committee of First Affiliated

研究疾病:

急性坏死性胰腺炎

Study Ailment:

Acute necrotizing pancreatitis

研究所处阶段:

Study phase:

Post-market

研究类型:

Type of Study:

Therapy Study

研究团队:

Research team:

研究实施地点:

Site of Study:

国家(地区):

中国

省(直辖市):

江西

市(区县):

南昌

Country/Area:

China

Province:

Jiangxi

City:

Nanchang
单位 南昌大学第一附属医院
Institution The First Affiliated Hospital of Nanchang University

预计起止时间:

Planned Duration:

2019-06-30 00:00:00-2020-12-31 00:00:00